dartmonkey

Prem and Patrick Byrne never complained about short-selling. They only complained about naked short-selling and coordinated attacks through certain analysts, media and hedge funds, who specifically created downward spiral attacks ... Lots of people complain about regular old short "attacks" - Elon Musk comes to mind. The mature response is exemplified by Reed Hastings of Netflix who says people are welcome to short the shares but that they are miguided. Virulent attacks against supposed short 'attacks' usually come from CEOs that have something to hide. This distinction between 'regular' short selling and 'naked' short selling is really a distinction without a difference. Naked or not, it is hard to see how short sales could do anything to influence the medium- to long-term price of a company's shares. I suspect Watsa likes Byrne (and maybe knows him through Byrne's father, who was CEO of GEICO and whom Buffett has called the Babe Ruth of insurance). Maybe he wanted to show some sympathy for him, or maybe he was convinced by Byrne's arguments, and Overstock was Fairfax's #5 US holding as recently as 2016. But Byrne really is a nut, heavily iinto conspiracy theories of all sorts (not just 'naked shorting'), and I am glad to see the Overstock stake was dumped and there's been no more talk from Watsa about this odd character. (Although I see that Francis Chou bought 44000 shares last year, about $1m worth, down about 40% now, that's a bit weird.)

Long term holders recall Fairfax had the temerity to sue the hedge funds for manipulating their stock on the NYSE. Although it was 15 years ago it's hard to get off their black list once your on it. Enough of my conspiracy theory... It is one of the few things I don't like about Watsa. The right approach to short sellers is Buffett's: "Be my guest." The wrong approach is Watsa's, which he has fortunately dropped for at least 20 years now. While it is true that Fairfax's share price has been depressed by short selling, it is not because someone has been shorting Fairfax; it is because someone at Fairfax has been shorting the index and tech high flyers, and that had catastrophic results. Fairfax's stock price continues to be unbelievably low, and I think this is primarily because many shareholders still remember those bad results from shorting, and are not yet giving Watsa the benefit of the doubt that he has actually seen the light and won't do it again.

Tammy is last week's news, or rather, it didn't really make it to mainstream news because it never looked like it had much of a chance of hitting the continental USA, as it has pointed farther and farther northeast. At this point, it is expected to stay 'way off shore, with high confidence'. At the worst, for those of us in the Eastern USA and Canada, it may give us a fair amount of rain. Looking this up, it is interesting that, although this is an El Niño year meaning we expect less hurricane activity, 2023 has turned out to be a fairly active tropical storm season, Tammy being #20 this year (T being the 20th letter in the alphabet). But fortunately for us and for Fairfax, most of them, except for Idalia, stayed where they belong, well offshore.

I think the table reverses the ‘available for sale’ categories, the no’s should be yes’es and vice versa

Berkshire 2022 AR (p. K-70). Hard to beat for short duration, and a nicely timed shift in 2022, just like Fairfax: December 31, 2022 2021 ASSETS Insurance and Other: Cash and cash equivalents* $32,260 $85,319 Short-term investments in U.S.TreasuryBills. 92,774 58,535 Investments in fixed maturity securities 25,128 16,434 Investments in equity securities 308,793 350,719 Equity method investments 28,050 16,045 ... Total 725,989 741,993

Despite my general dislike of Trudeau and his inept woke government, I was prepared to give them the benefit of the doubt regarding this spat with India - you can’t just stand by when a Canadian citizen is murdered in Canada by a foreign government. But I may have been wrong to presume we had good evidence for this serious allegation : https://nationalpost.com/opinion/canadas-remarkably-slapdash-assassination-accusation

That would indeed be worrisome, given Watsa's pretty unambiguous promise in the 2018 report: In the past, to protect our equity exposures in uncertain times, we shorted indices (mainly the S&P500 and Russell 2000) and a few common stocks. After much thought and discussion, it became clear to me that shorting is dangerous, very short term in nature and anathema to long term value investing. As I mentioned to you in last year’s annual report, shorting has cost us, cumulatively, net of our gains on common stock, approximately $2 billion! This will not be repeated! In the future, we may use options with a potential finite loss to hedge our equity exposure, but we will never again indulge anew in shorting with uncapped exposure. Your Chairman continues to learn–slowly!! repeated in 2021: I said in our 2019 [sic; but I think he meant 2018] annual report that we would not short stock market indices (like the S&P500) or common stocks of individual companies ever again, and our last remaining short position was closed out in 2020 (not soon enough, as it cost us $529 million in 2020). If he renegs on this promise, I think people would be furious. Even though I think shorting the market would probably work out well at current prices, with the company doing so well since the end of the shorts, I dare to hope that he has ruled out shorting too clearly for him to just go back to doing it again.

Agreed about the S&P, but it's small ($30m), I wonder if they acquired it somehow and haven't gotten rid of it yet. Seems contrary to everything they usually say and do. As for Occidental, at $354m it may be #1 in the 13-F, but it's really small potatoes compared to the huge bond portfolio, the big private companies they own, notably Eurobank and Atlas/Poseidon (each about $2b). Even Thomas Cook is bigger (about $400m), and Mytilineos is about the same size as the Occidental bet. And of course, the dreaded Blackberry is even smaller, fading into obscurity (thankfully!)

Exactly. I like to think my portfolio is half cash, half conservative stocks. Except that the cash half is actually levered 2:1, plus a dollop of underwriting income and savvy investing in gems like Eurobank, Poseidon and (lest we forget the downside) Blackberry...

Yes, there is a recent thread on this forum about historic landmarks, but maybe one landmark that we are within spitting distance of touching is price to book, which is getting close to 1. Q1 common shareholders' equity $18,663.8m (USD), market cap $18.574 as I speak (using the FRFHF quote). We will have a new book value in a few days, and it will be much higher than $18.6b (any guesses?), so we will still be trading well beneath book value, but it's heading in that direction...

I'd just as soon it doesn't get so big that it can't keep the same high returns on capital, and repurchasing stock (especially over the last few years, but even now) is a good way of doing that. And, together with the dividend, it makes it hard to compare with other Canadian companies that have more or less return of capital to investors. But more important to me is that MY market cap keeps climbing up, even if Fairfax's stays the same because it is pouring more into my account...

It seems to me that this possibility of more climate change disasters (although this is more of a fear than a current reality) is an opportunity for insurers, not a threat. Of course if the risk increases, rates will have to go up, but this just expands the total addressable market of the insurance industry. In the same way that fully self-driving cars might drastically shrink the auto insurance industry, more hurricanes or flooding or fires might expand it. That may not be good for humans, but it’s good for insurance companies.

Yes, every time I see a FIH report indicating how brilliantly this tiny investment is doing, I have another little wrench...

Yes, of course you are right, I just used the same dates that Brooklyn Investor used to show that Berkshire is the real thing, the Berkshire wannabees are also-rans. I just wondered if that particular fairly non-natural 11.5y period might have been not quite so bad, if one counted dividends. The answer is no, it takes us from 4.6 to 6.9% annualized, still a long way from Berkshire's 13.9%. Of course Fairfax looks a lot better if you include the big macro bet put on before the global financial crisis that paid off handsomely. And the period chosen is the almost the worst imaginable period for Fairfax, beginning about the same time as the catastrophic shorting adventure. hopefully behind us now forever. Going back a bit farther, things are not so bad. And also, hopefully, going forwards a bit farther will do the same trick...

I did the calculation too, since I wasn't sure whether Brooklyn Investor had included the dividends. You can do it with FRFHF in USD ($10 dividend every year) or with FIH in CAD ($10US dividend converted to CAD at prevailing exchange rate). There's still a big gap with BRK, but it does narrow a bit: So 13.9% from Berkshire, and 6.9% from Fairfax still hurts, but it's not as bad as the 4.6% you would calculate if you ignored the dividend. FIH gets a better return, but only because the exchange rate has gone from rough parity in 2011 to 1.33 now. To compare apples with apples, Berkshire's 13.9% in USD has to be compared to the FRFHF return in USD; a Berkshire investment in USD would be even better than 13.9% annualized for a Canadian, who would also benefit from having invested in USD. Boy, it's pretty depressing typing in those FRFHF share price numbers, going nowhere, with share price lower in January 2021 than in December 2011, almost 10 years prior. Hopefully that's over at last!

Agreed. Remembering the successful Bank of Ireland investment, they purchased 8.7% in 2011 for 0.10 eurs, and sold most of it in 2014 and 2015 for between 0.33 and 0.36 euros, and cut it further from 2.9% to 1.5% in 2016, and the rest in 2017, for a total profit of over $1b US. (In the 2002 AR, Watsa called Richie Boucher from the Bank of Ireland Fairfax's 'first billion dollar man', with George Chryssikos's of Grivalia and Eurobank having his name added to this illustrious list. Interestingly, Boucher was on Eurobank's board from 2017 to 2020, so maybe it's contagious.) Anyways, the Bank of Ireland has not done much since 2017, going from about 8 euros to 9, and paying out 0.67 euros since then. Hopefully, Eurobank will not suffer the same fate, but if Fairfax lightens its investment a bit, there would be a good precedent.

According to the Q1 report, their bond position went from $29,001 on Dec 31st to $32,545 on Mar 31st, so they basically invested $2.5b of cash into bonds. 2y rates went from about 4% in January, to a peak of 5% in early March, and then back down to around 4% for most of April and May, and then, late May and June back up to almost 5%, as you note. 1y yields are a little higher, 3y yields a little lower. When I saw they had put about $1.4b of cash and short term investments, plus another $1b of Q1 earnings, into 1-3y treasury bonds with a duration of about 3 years, but not more, I thought they had maybe waited a bit too long again, but no, rates are back up to 5%. Would it have been better if they had hit the top 5% treasury yields (mid-March or right now)? Should they have held out for even higher rates? Who knows, but I am glad they have locked in $1.5b of interest and dividends for the next 3 years. They have some pretty significant earnings coming in this quarter (closing of Ambridge, for instance), so they may be able to sweeten the interest income stream a bit more, now, we will see. But with their pretty stellar track record of getting their macro interest rate calls right, over the years, so I am not going to criticize them for not hitting the exact peak.

The modeled probability of aggregate catastrophe losses in any one year exceeding this amount is generally more than once in every 250 years." It reads as though they mean greater than one event in 250 years, which would be greater than 0.4% chance per year with no upper limit. Yes, I'm sure from the context that they meant that the modeled probability of losing 15% of equity in any one year is LESS than 0.4%, not more, which would not be reassuring!

I think we agree, although you and I are both having trouble with typos! You mean it will compound nicely, if the share price (not book value) gets back to something around 1x book, right? And as Haryana more clearly put it, there are no fees (or, more precisely, only 20c of fees) up to the most recent book value, and only 1/5 of book value gains beyond 5% per annum, for book values higher than $18.85/share. Lots of asset managers and their shareholders have to live with share prices below asset value: Pershing Square is another good example. So a return of the share price to 1x book may be a bit optimistic, although of course it would boost returns a lot if it ever happens. But even if it doesn't, and we only track BV, returns are already not bad - despite a few lost years from the COVID scare and its devastating effects on the airport, along with a weakening rupee, BV growth per share was 8.5% up to last December. Even without a share value:book value narrowing, I could live with 10% BV growth, and won't begrudge Fairfax from taking one of those percentage points for its fee.

Not exactly. Book value is now $18.85 per share by my calculation (March 31st equity $2,598,273,000; shares 137,815,952), share price $13.65, but don't forget the fees have already been paid for book value up to . Fees are paid based on book value, not share price, and they are 1/5 of BV increase beyond a 5% annually (this December 31st is the end of the 3rd 3y calculation period). They are paid every 3 years if book value is higher than the previous highwater mark, but (I think) not reimbursed if there is a book value drop. But they are accrued, based on each trimester's BV, and as of March 31, there was a fee accrual of 20c/share. In other words, there is 20c per to be paid if book value on December 31st is the same as it is now. But whether the share price climbs up to book value of not makes no difference to the fee.

How about this: 2019: In the past, to protect our equity exposures in uncertain times, we shorted indices (mainly the S&P500 and Russell 2000) and a few common stocks. After much thought and discussion, it became clear to me that shorting is dangerous, very short term in nature and anathema to long term value investing. As I mentioned to you in last year’s annual report, shorting has cost us, cumulatively, net of our gains on common stock, approximately $2 billion! This will not be repeated! In the future, we may use options with a potential finite loss to hedge our equity exposure, but we will never again indulge anew in shorting with uncapped exposure. Your Chairman continues to learn–slowly!! 2020: I said in our 2019 annual report that we would not short stock market indices (like the S&P500) or common stocks of individual companies ever again, and our last remaining short position was closed out in 2020 (not soon enough, as it cost us $529 million in 2020).

Sorry,, I mean $1013, up $23...

Even worse now, $1023! I hope the company has bought back a lot of shares since the first quarter report, but this opportunity for reinvesting way below intrinsic value may be closing up now. It will be interesting to see at what price they stop the repurchases.

Yes, there doesn't seem to be any indication that this is a distressed sector like office space. With 70% being multifamily/student housing, and the rest in industrial/hotel/life science office property, it doesn't seem like the LTV would be any different now from when the loans were initiated. I don't exactly know what 'science office property' is, but while the word 'office' is scary, in these work-from-home tiimes, from the way the deal is described, it doesn't seem like it should be a big part of the deal.

From the Dec 2022 PR, we know the Fairfax stake went from 3.985m to 6.688m (by virtue of buying 50m EU worth, at 18.50EU/share), and that they can buy another 50m EU worth at 20/sh. And that at some point in 2014, they had 7m shares. In Fairfax's 2016 AR, they had shres with a cost basis of 35.5m EU, which sounds like those 7m shares bought at around 5EU, ut then a year later, they had shares with a cost basis of 15.9m EU, so I guess they had sold a bit more than half. No mention of these shares in Fairfax's ARs for 2018-2019-2020, but then they had 3.7m shares in the 2021, and 4m by the end of 2022. So did they have those 3.7m all along, and just stop reporting them for a few years for some reason? And then bought 0.3m more in 2022, to get up to 4m, before buying their latest stake in December? I guess that's the simplest explanation. That would mean that there were 3.7m shares with a cost basis of 5.13 EU (announced in Mytilineos's 2013 AR you cited), and another 0.3m bought last year, so at about 15 EU/sh. That would mean that their cost basis was lower, only 123m EU, no 154m, so at the current value of 267m, they are sitting on a gain of 114%. But it is better to think of an investment in 2 phases: one of 4m shares owned for 10 years, up from 5 to 29EU (along with some profit taking from 3m shares sold in 2017, for an unknown amount), and the other one of 5.2m shares, up 50% in 6 months. Both (or probably, all 3) are more than satisfactory, to say the least.